Ionis Pharmaceuticals Logo

Ionis Pharmaceuticals

🇺🇸
IONS
US4622221004

Ionis Pharmaceuticals is a leading biopharmaceutical company dedicated to discovering and developing innovative RNA-targeted therapeutics. The company's primary focus is on treating rare and devastating diseases, particularly neurological disorders, leveraging groundbreaking antisense technology. Ionis is revolutionizing drug discovery to provide new treatment options for patients globally, aiming to significantly improve their quality of life.

Next Quarterly Earnings

Wednesday, August 5, 2026
CW 32
Pre-Market
In 31 days

Stock Price

All Dates

Company Information

Name
Ionis Pharmaceuticals
Ticker Symbol
IONS
ISIN
US4622221004
Country
🇺🇸
USA